ZA958892B - Injection-molded dosage form - Google Patents

Injection-molded dosage form

Info

Publication number
ZA958892B
ZA958892B ZA958892A ZA958892A ZA958892B ZA 958892 B ZA958892 B ZA 958892B ZA 958892 A ZA958892 A ZA 958892A ZA 958892 A ZA958892 A ZA 958892A ZA 958892 B ZA958892 B ZA 958892B
Authority
ZA
South Africa
Prior art keywords
injection
dosage form
molded dosage
poly
molded
Prior art date
Application number
ZA958892A
Other languages
English (en)
Inventor
Liang C Dong
Patrick S-L Wong
Crystal Pollock
Vincent Joseph Ferrari
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of ZA958892B publication Critical patent/ZA958892B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
    • C08L67/04—Polyesters derived from hydroxycarboxylic acids, e.g. lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/06—Organic material
    • B01D71/48—Polyesters
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08—Cellulose derivatives
    • C08L1/26—Cellulose ethers
    • C08L1/28—Alkyl ethers
    • C08L1/284—Alkyl ethers with hydroxylated hydrocarbon radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA958892A 1994-10-28 1995-10-20 Injection-molded dosage form ZA958892B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/330,892 US5614578A (en) 1994-10-28 1994-10-28 Injection-molded dosage form

Publications (1)

Publication Number Publication Date
ZA958892B true ZA958892B (en) 1996-07-05

Family

ID=23291759

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA958892A ZA958892B (en) 1994-10-28 1995-10-20 Injection-molded dosage form

Country Status (13)

Country Link
US (2) US5614578A (xx)
EP (2) EP0782440B1 (xx)
JP (1) JPH10508023A (xx)
KR (2) KR100451782B1 (xx)
AT (2) ATE244554T1 (xx)
AU (1) AU695739B2 (xx)
CA (1) CA2200746C (xx)
CY (1) CY2489B1 (xx)
DE (2) DE69531263T2 (xx)
ES (1) ES2203395T3 (xx)
NZ (1) NZ295982A (xx)
WO (1) WO1996013248A1 (xx)
ZA (1) ZA958892B (xx)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614578A (en) * 1994-10-28 1997-03-25 Alza Corporation Injection-molded dosage form
US5773500A (en) * 1996-05-14 1998-06-30 Amoco Corporation Flame retardant high temperature polyphthalamides having improved thermal stability
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
WO1998023263A1 (en) * 1996-11-25 1998-06-04 Alza Corporation Ascending-dose dosage form
WO1999018159A1 (en) * 1997-10-06 1999-04-15 Alza Corporation Injection-moldable composition and article of manufacture comprising same
US6197324B1 (en) 1997-12-18 2001-03-06 C. R. Bard, Inc. System and methods for local delivery of an agent
US6251418B1 (en) 1997-12-18 2001-06-26 C.R. Bard, Inc. Systems and methods for local delivery of an agent
EP1045885A1 (en) 1998-02-06 2000-10-25 Union Carbide Chemicals & Plastics Technology Corporation Alkylene oxide polymer compositions
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6183466B1 (en) 1998-08-21 2001-02-06 Alza Corporation Dosage form comprising a capsule
US6099862A (en) 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
US6551613B1 (en) * 1998-09-08 2003-04-22 Alza Corporation Dosage form comprising therapeutic formulation
US6174547B1 (en) 1999-07-14 2001-01-16 Alza Corporation Dosage form comprising liquid formulation
US6689121B1 (en) 1998-09-24 2004-02-10 C. R. Bard, Inc. Systems and methods for treating ischemia
US6432126B1 (en) 1998-09-30 2002-08-13 C.R. Bard, Inc. Flexible vascular inducing implants
US6248112B1 (en) 1998-09-30 2001-06-19 C. R. Bard, Inc. Implant delivery system
US6251079B1 (en) 1998-09-30 2001-06-26 C. R. Bard, Inc. Transthoracic drug delivery device
US6458092B1 (en) 1998-09-30 2002-10-01 C. R. Bard, Inc. Vascular inducing implants
US6692520B1 (en) 1998-12-15 2004-02-17 C. R. Bard, Inc. Systems and methods for imbedded intramuscular implants
CA2354472C (en) * 1998-12-17 2009-02-24 Alza Corporation Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
US6986784B1 (en) 1999-05-14 2006-01-17 C. R. Bard, Inc. Implant anchor systems
US6719805B1 (en) * 1999-06-09 2004-04-13 C. R. Bard, Inc. Devices and methods for treating tissue
US6491683B1 (en) 1999-09-07 2002-12-10 Alza Corporation Osmotic dosage form composed of an extruded polymer tube form
EP1239840B1 (en) * 1999-12-09 2005-04-06 Alza Corporation Antiviral medication
OA12128A (en) * 1999-12-23 2006-05-05 Pfizer Prod Inc Hydrogel-driven drug dosage form.
US7204847B1 (en) 2000-07-28 2007-04-17 C. R. Bard, Inc. Implant anchor systems
US6866866B1 (en) * 2000-11-03 2005-03-15 Andrx Labs, Llc Controlled release metformin compositions
US20060034922A1 (en) * 2000-11-03 2006-02-16 Andrx Labs, Llc Controlled release metformin compositions
US6790459B1 (en) 2000-11-03 2004-09-14 Andrx Labs, Llc Methods for treating diabetes via administration of controlled release metformin
JP2002331522A (ja) * 2001-05-09 2002-11-19 Dai Ichi Kogyo Seiyaku Co Ltd 親水性樹脂粒状体の製造方法
GB0120835D0 (en) * 2001-08-28 2001-10-17 Smithkline Beecham Plc Process
US20040213848A1 (en) 2001-09-28 2004-10-28 Shun-Por Li Modified release dosage forms
US7122143B2 (en) * 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US7217381B2 (en) 2001-09-28 2007-05-15 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US6767200B2 (en) * 2001-09-28 2004-07-27 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
US6742646B2 (en) * 2001-09-28 2004-06-01 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
AU2003241537A1 (en) * 2002-05-23 2003-12-12 Andrx Corporation Biguanide formulations
US6583225B1 (en) * 2002-06-21 2003-06-24 Isp Investments Inc. Polymeric hydrogels
AR039744A1 (es) * 2002-06-26 2005-03-09 Alza Corp Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
AR040306A1 (es) * 2002-06-28 2005-03-23 Alza Corp Capsula de liberacion controlada para la administracion de formulacion liquida
US20050232995A1 (en) * 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
EP1534238A1 (en) * 2002-07-29 2005-06-01 ALZA Corporation Formulations and dosage forms for controlled delivery of topiramate
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US20040142040A1 (en) * 2002-10-31 2004-07-22 Dong Liang C. Formulation and dosage form providing increased bioavailability of hydrophobic drugs
US20040091538A1 (en) * 2002-10-31 2004-05-13 Crystal Pollock-Dove Dosage form providing ascending release of liquid formulation
US7135436B2 (en) * 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
CN1859897A (zh) * 2003-07-31 2006-11-08 阿尔扎公司 用于液态活性剂制剂控制释放的抗渗透的渗透装置和剂型
WO2005016306A2 (en) * 2003-08-06 2005-02-24 Alza Corporation Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
JP2007503389A (ja) * 2003-08-22 2007-02-22 アルザ・コーポレーシヨン 長期間にわたるトピラメートの段階的送達
WO2005020959A2 (en) * 2003-09-02 2005-03-10 Alza Corporation Novel drug compositions and dosage forms of topiramate
US20050186273A1 (en) * 2003-09-26 2005-08-25 Si-Hong Yum Controlled release dosage form including a banded engine
ATE504288T1 (de) * 2003-09-26 2011-04-15 Alza Corp Oros-push-stick für die kontrollierte abgabe von wirkstoffen
MXPA06003452A (es) * 2003-09-26 2006-08-31 Johnson & Johnson Formulaciones de liberacion controlada que exhiben una velocidad de liberacion ascendente.
WO2005030165A1 (en) * 2003-09-26 2005-04-07 Alza Corporation Dosage form for controlled release of an active agent formulation
JP5563731B2 (ja) * 2003-09-26 2014-07-30 アルザ・コーポレーシヨン オピオイドおよび非オピオイド鎮痛薬の制御放出製剤
EP2184058B1 (en) 2003-09-26 2012-02-08 ALZA Corporation Drug coating providing high drug loading and methods for providing the same
US20050074514A1 (en) * 2003-10-02 2005-04-07 Anderson Oliver B. Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms
TW200528144A (en) * 2003-11-14 2005-09-01 Alza Corp Controlled release of topiramate in liquid dosage forms
MXPA06007510A (es) * 2003-12-29 2009-06-10 Johnson & Johnson Composiciones de farmaco y formas de dosis novedosas de topiramato.
MXPA06007509A (es) * 2003-12-29 2007-10-18 Johnson & Johnson Composiciones de farmaco y formas de dosis novedosas.
US20050175696A1 (en) * 2003-12-29 2005-08-11 David Edgren Drug granule coatings that impart smear resistance during mechanical compression
US20050196447A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196446A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196442A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196448A1 (en) * 2004-03-05 2005-09-08 Hai Yong Huang Polymeric compositions and dosage forms comprising the same
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
CN101232868A (zh) * 2005-04-19 2008-07-30 阿尔扎公司 曲马多和加巴喷丁的控释递药剂型
AR055099A1 (es) * 2005-07-28 2007-08-08 Alza Corp Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
PL116330U1 (en) * 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
WO2008052219A2 (en) * 2006-10-27 2008-05-02 Goody Products, Inc. Therapeutics styling tool with infusion delivery
US7832413B2 (en) * 2006-10-27 2010-11-16 Goody Products, Inc. Therapeutic styling brush with infusion delivery
US7845360B2 (en) 2006-10-27 2010-12-07 Goody Products, Inc. Therapeutic styling brush with infusion delivery
US8524749B2 (en) * 2007-02-09 2013-09-03 Alza Corporation Controlled release compositions of tizanidine
WO2010080449A1 (en) * 2008-12-18 2010-07-15 Adds Pharmaceuticals Llc Blow-molded thin-walled drug delivery capsules
JP5641483B2 (ja) 2009-08-18 2014-12-17 国立大学法人東北大学 持続性ドラッグデリバリーシステム
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
US10166207B2 (en) 2013-06-05 2019-01-01 Synchroneuron, Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) * 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US5213809A (en) * 1990-01-24 1993-05-25 Alza Corporation Delivery system comprising means for controlling internal pressure
KR920005648B1 (ko) * 1990-03-31 1992-07-11 정종평 항생활성 성분의 치과용 국소 지속성 투여 조성물
WO1992013521A1 (en) * 1991-01-30 1992-08-20 Alza Corporation Osmotic device for delayed delivery of agent
CA2065966A1 (en) * 1991-04-23 1992-10-24 Robert J. Petcavich Disposable recyclable plastic articles and moldable synthetic resin blends for making the same
US5614578A (en) * 1994-10-28 1997-03-25 Alza Corporation Injection-molded dosage form

Also Published As

Publication number Publication date
EP1057478A2 (en) 2000-12-06
KR100408103B1 (ko) 2004-04-14
CY2489B1 (en) 2005-06-03
CA2200746A1 (en) 1996-05-09
US5830502A (en) 1998-11-03
ES2203395T3 (es) 2004-04-16
DE69521901T2 (de) 2001-11-15
KR100451782B1 (ko) 2004-10-08
DE69531263T2 (de) 2004-05-13
WO1996013248A1 (en) 1996-05-09
KR20030097606A (ko) 2003-12-31
ATE244554T1 (de) 2003-07-15
EP1057478A3 (en) 2001-09-19
AU3966095A (en) 1996-05-23
EP0782440A1 (en) 1997-07-09
NZ295982A (en) 1998-05-27
DE69531263D1 (de) 2003-08-14
CA2200746C (en) 2007-11-20
AU695739B2 (en) 1998-08-20
JPH10508023A (ja) 1998-08-04
DE69521901D1 (de) 2001-08-30
MX9703111A (es) 1997-07-31
KR970706793A (ko) 1997-12-01
EP0782440B1 (en) 2001-07-25
EP1057478B1 (en) 2003-07-09
US5614578A (en) 1997-03-25
ATE203396T1 (de) 2001-08-15

Similar Documents

Publication Publication Date Title
ZA958892B (en) Injection-molded dosage form
BR9609176A (pt) Composi-{es de agente biolÄgico
GB2191446B (en) Stabilized molded rubber keyboards.
DE69329878D1 (de) Mri-zusammensetzungen, basiert auf poly(alkylenoxid)
DE69113810D1 (de) (poly)sulfid enthaltende polycitraconimide und polyitaconimide.
MY101292A (en) Hair care compositions
DK0568525T3 (da) Subkutan sprøjte.
EP0372752A3 (en) Cd4 polypeptide derivatives
IT8921066A0 (it) Composizioni polimeriche autoestinguenti.
DE3783700D1 (de) Yttriumoxid-keramikformkoerper.
ZA917486B (en) Polymeric endoscopic ligature.
DE69018323D1 (de) Formkörper.
ES522225A0 (es) Maquina de inyeccion, estirado y moldeo por soplado.
DE69020847D1 (de) Kern-Schalen-Polymer, Harzzusammensetzung und daraus geformte Gegenstände.
MC1884A1 (fr) Variants de l'hirudine,leur utilisation et leur preparation
IE960874L (en) Macif protein, genes coding therefor, expression vectors¹containing said genes, and transformant cells containing¹said protein
IT8621450A0 (it) Composizione sterilizzante adattivita' antibatterica e antimicetica a base di glutaraldede, in veicolo acquoso.
DE68916717D1 (de) Selbstverlöschende Polymer-Zusammensetzung.
DE69108020D1 (de) Polymerzusammensetzung, und daraus hergestellte Formkörper.
IT8720350A0 (it) Procedimento per la fabbricazione tramite iniezione di contenitori, in particolare contenitori aventi incorporata un'etichetta.
EP0401262A4 (en) 24r-scymnol, and preparation and use thereof
DE58906999D1 (de) Oxetanylgruppen enthaltende thermoplastische Formmassen.
NO873384D0 (no) Etylen- og alfa-cyanacrylatholdige kopolymere.
DE69014285T2 (de) Reaktionsspritzgusszusammensetzung.
EP0343246A4 (en) ULTRAVIOLET ABSORBING POLYMER MATERIAL.